Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-11 4:30 pm Sale | 13G | Fresh Tracks Therapeutics Inc. FRTX | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -664,079 (Position Closed) | View |
2021-02-11 4:22 pm Purchase | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 11,180,994 6.6% | 4,852,000 (+76.66%) | View |
2021-02-01 5:19 pm Purchase | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | BIOTECHNOLOGY VALUE FUND L P | 3,138,678 7.2% | 1,875,000 (+148.38%) | View |
2021-01-29 4:36 pm Sale | 13D | PHAXIAM THERAPEUTICS S.A. AMER PHXM | BIOTECHNOLOGY VALUE FUND L P | 4,081,941 20.4% | -380,000 (-8.52%) | View |
2021-01-26 5:26 pm Sale | 13D | INFINITY PHARMACEUTICALS INC C INFIQ | BIOTECHNOLOGY VALUE FUND L P | 10,726,968 16.7% | -6,700,000 (-38.45%) | View |
2021-01-19 5:21 pm Purchase | 13G | Aileron Therapeutics Inc. ALRN | BIOTECHNOLOGY VALUE FUND L P | 5,265,555 6.3% | 5,265,555 (New Position) | View |
2021-01-14 4:48 pm Sale | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,916,658 11% | -3,425,847 (-30.20%) | View |
2021-01-13 4:56 pm Sale | 13G | CYTOKINETICS INC CYTK | BIOTECHNOLOGY VALUE FUND L P | 2,728,035 3.9% | -4,629,984 (-62.92%) | View |
2021-01-12 5:10 pm Unchanged | 13D | PHAXIAM THERAPEUTICS S.A. AMER PHXM | BIOTECHNOLOGY VALUE FUND L P | 4,461,941 22.3% | 0 (Unchanged) | View |
2021-01-11 5:06 pm Purchase | 13G | Gritstone bio Inc. GRTS | BIOTECHNOLOGY VALUE FUND L P | 2,695,418 6.5% | 2,695,418 (New Position) | View |
2020-12-30 5:27 pm Purchase | 13G | Eledon Pharmaceuticals Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,518,039 10% | 3,520 (+0.23%) | View |
2020-12-28 5:13 pm Purchase | 13G | Eledon Pharmaceuticals Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,514,519 9.99% | 1,319,193 (+675.38%) | View |
2020-12-21 4:37 pm Purchase | 13G | LEXICON PHARMACEUTICALS INC. LXRX | BIOTECHNOLOGY VALUE FUND L P | 10,963,000 7.8% | 10,963,000 (New Position) | View |
2020-12-15 5:21 pm Unchanged | 13D | XOMA Corp XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 37.9% | 0 (Unchanged) | View |
2020-12-10 5:16 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | BIOTECHNOLOGY VALUE FUND L P | 2,752,222 4.2% | -826,801 (-23.10%) | View |
2020-11-20 5:23 pm Purchase | 13D | Olema Pharmaceuticals Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 6,661,503 16.6% | 6,661,503 (New Position) | View |
2020-11-16 5:29 pm Purchase | 13G | CYTOKINETICS INC CYTK | BIOTECHNOLOGY VALUE FUND L P | 7,358,019 10.4% | 3,419,739 (+86.83%) | View |
2020-11-13 5:27 pm Sale | 13D | FIVE PRIME THERAPEUTICS INC. FPRX | BIOTECHNOLOGY VALUE FUND L P | 1,263,678 3.3% | -7,100,675 (-84.89%) | View |
2020-11-12 5:13 pm Unchanged | 13D | INFINITY PHARMACEUTICALS INC C INFIQ | BIOTECHNOLOGY VALUE FUND L P | 17,426,968 27.1% | 0 (Unchanged) | View |
2020-11-12 5:11 pm Purchase | 13G | CALLIDITAS THERAPEUTICS AB SPO CALT | BIOTECHNOLOGY VALUE FUND L P | 7,431,562 14.9% | 2,650,000 (+55.42%) | View |